Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant610 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00965861 | SCRI Tissue Testing Registry | terminated | — | 20 | SCRI Development Innovations, LLCOTHER | 1 | Aug 28, 2013 | clinicaltrials |
| NCT00757614 | Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom | unknown | — | 14,000 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01018004 | Comparing Follow-Up Schedules in Patients With Newly Diagnosed Stage IB or Stage II Melanoma | unknown | — | 178 | University Medical Center GroningenOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01082198 | Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes | unknown | Phase 1 / Phase 2 | 22 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01217398 | Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye | unknown | Phase 2 | 35 | Institut CurieOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00246012 | A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma | completed | Phase 1 / Phase 2 | 144 | Centocor, Inc.INDUSTRY | 3 | Aug 19, 2013 | clinicaltrials |
| NCT00445783 | Study of Families With Melanoma | unknown | — | 3,700 | Leeds Cancer Centre at St. James's University HospitalOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00450593 | Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma | unknown | — | 5,000 | Leeds Cancer Centre at St. James's University HospitalOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00672321 | Answering Questions About Vitamin D Supplementation and Sun Exposure in Patients Who Have Undergone Surgery for Stage IB, Stage II, or Stage IIIA Melanoma | unknown | — | 2,774 | Leeds Cancer Centre at St. James's University HospitalOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00897481 | Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy | unknown | — | 1,000 | Leeds Cancer Centre at St. James's University HospitalOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00002455 | Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma | unknown | Phase 3 | — | Centro Oncologico de ExcelenciaOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00563823 | Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery | completed | Phase 2 | 34 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00707174 | Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna | completed | N/A | 90 | University of UtahOTHER | 1 | Jul 31, 2013 | clinicaltrials |
| NCT00745862 | Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma | completed | — | 118 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 25, 2013 | clinicaltrials |
| NCT00466687 | Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma | completed | Phase 2 | 34 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 22, 2013 | clinicaltrials |
| NCT00815607 | Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma | completed | Phase 1 | 12 | Alaunos TherapeuticsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00003789 | Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg | completed | Phase 3 | 216 | National Cancer Institute (NCI)NIH | 1 | Jul 16, 2013 | clinicaltrials |
| NCT01011530 | Dose Escalation Study of MLN4924 in Adults With Melanoma | completed | Phase 1 | 37 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 16, 2013 | clinicaltrials |
| NCT00722098 | Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients | terminated | Phase 2 | 9 | Baylor Research InstituteOTHER | 1 | Jul 8, 2013 | clinicaltrials |
| NCT00003022 | Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00948467 | Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies | completed | Phase 1 | 51 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00002535 | Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma | completed | Phase 2 | — | St. Luke's Medical CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00003568 | Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma | completed | Phase 2 | — | University of Illinois at ChicagoOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00003792 | Vaccine Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 1 | — | Baylor Health Care SystemOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00039572 | Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain | completed | Phase 1 / Phase 2 | — | Beth Israel Deaconess Medical CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00059800 | Boron Neutron Capture Therapy in Treating Patients With Melanoma | completed | Phase 2 | — | Beth Israel Deaconess Medical CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00104897 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma | completed | Phase 2 | 25 | Cancer Research UKOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00003346 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 2 | 80 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00003362 | Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00287196 | Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes | completed | Phase 3 | 250 | Trans Tasman Radiation Oncology GroupOTHER | 4 | Jun 25, 2013 | clinicaltrials |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00026520 | Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma | completed | Phase 2 | — | SWOG Cancer Research NetworkNETWORK | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00042783 | Vaccine Therapy in Treating Patients With Stage IV Melanoma | completed | Phase 2 | — | SWOG Cancer Research NetworkNETWORK | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00019214 | Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019331 | Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019383 | Vaccine Therapy in Treating Patients With Recurrent or Refractory Metastatic Melanoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019487 | Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019669 | Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019721 | Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019734 | Vaccine Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00032045 | Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00058279 | Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00082914 | Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00416988 | Educational Program in Skin Self-Examination To Detect Melanoma in Healthy Participants | completed | N/A | 1,135 | Rhode Island HospitalOTHER | 0 | Jun 20, 2013 | clinicaltrials |
| NCT00005633 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00005815 | Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00019994 | Vaccine Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00020358 | Vaccine Therapy in Treating Patients With Melanoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00020397 | Vaccine Therapy in Treating Patients With Refractory Metastatic Melanoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00021164 | Vaccine Therapy in Treating Patients With Metastatic Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Aug 28, 2013source: clinicaltrials